Results 81 to 90 of about 10,409 (344)

Analiza spletne prodajalne ZKP RTV Slovenija

, 2019
Ključna naloga vsake spletne trgovine je zadovoljiti potrebe uporabnikov ter poskrbeti, da bo njihova uporabniška izkušnja čimbolj prijetna in pozitivna.
Zajc, Nastja
core  

Internal communication in time of rebranding - case study A1 Slovenija, d. d.

, 2021
Osrednja tema magistrskega dela je interno komuniciranje v času spremembe blagovne znamke. V prvem delu se dotaknemo teoretičnih izhodišč korporativnega in internega komuniciranja, vlogi blagovne znamke v organizaciji, s pomočjo katerih bi omogočili ...
Stegnjaić, Nada
core  

A Multifaceted Interplay Among Hemophagocytosis, Interleukin‐18, and Type I Interferon Distinguishes Still Disease From Other Autoinflammatory Diseases

Arthritis &Rheumatology, EarlyView.
Objective The unknown pathophysiology and the lack of specific features for systemic juvenile idiopathic arthritis and adult‐onset Still disease (collectively known as Still disease; SD) delay diagnosis and appropriate treatment. The goal of this study was to identify features and mechanisms that distinguish SD from other systemic autoinflammatory ...
Yvonne M. Mueller, Charlotte Girard, Harmen J. G. van de Werken, Stefan J. Erkeland, Dwin G. B. Grashof, Laurie Vaillant, Renske J. H. den Dekker, Iris van Zuijen, Sharon Veenbergen, Fanny Coffin, Eric Bindels, Yvan Jamilloux, Katerina Laskari, Vassili Soumelis, Bruno Fautrel, Cem Gabay, Peter D. Katsikis   +16 more
wiley   +1 more source

Machine Learning to Predict Remission Between 6 and 24 Months in Rheumatoid Arthritis: Insights From JAK, an International Registry Collaboration

Arthritis &Rheumatology, EarlyView.
Objective To develop, externally validate, and simplify a machine learning model to predict remission between 6 and 24 months in patients with rheumatoid arthritis (RA) initiating tumor necrosis factor inhibitors, JAK inhibitors, interleukin‐6 inhibitors, abatacept, or rituximab using data from 11 international registries in the JAK‐pot collaboration ...
Zubeyir Salis, Denis Mongin, Denis Choquette, Louis Coupal, Catalin Codreanu, Florenzo Iannone, Roberto Caporali, Tore K. Kvien, Sella Provan, Ruth Fritsch‐Stork, Dan Nordström, Nina Trokovic, Karel Pavelka, Jakub Závada, Ana Rodrigues, Ziga Rotar, Prodromos Sidiropoulos, Irini Flouri, Céline Lamacchia, Michele Iudici, Delphine Courvoisier, Kim Lauper, Axel Finckh   +22 more
wiley   +1 more source

Scaling of Planar Sodium‐Nickel Chloride Battery Cells to 90 cm2 Active Area

Batteries &Supercaps, Volume 8, Issue 3, March 2025.
Large planar Na β′′ alumina electrolytes are prepared by tape‐casting and die‐pressing. These ceramic electrolytes are used to prepare planar sodium‐nickel chloride cells with 90 cm2 active area, providing a high capacity of 7 Ah. Successful cell cycling is demonstrated at 300 °C at rates up to C/4 (20 mA cm−2) for a cumulative capacity of 3.6 Ah cm−2.
T. Lan, E. Svaluto‐Ferro, N. Kovalska, G. Graeber, F. Vagliani, D. Basso, A. Turconi, M. Makowska, G. Blugan, C. Battaglia, M. V. F. Heinz   +10 more
wiley   +1 more source

Stock management in company Roto Slovenija d.o.o.

, 2018
Skoraj ni podjetja, ki se ne bi srečevalo s problemom zalog, ker so le-te vezane v obratna sredstva. Cilj vsakega je tako poskrbeti za optimalne zaloge, ob hkratnem normalnem delovanju, torej utečeni prodaji in izdobavi.
Vöröš, Katja
core  

Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis

British Journal of Clinical Pharmacology, EarlyView.
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley   +1 more source

Bronhiektazije: strokovne usmeritve za obravnavo na primarni, sekundarni in terciarni ravni

Zdravniški Vestnik
Bronhiektazije so kronična vnetna bolezen pljuč, za katero so značilne pridobljene trajne razširitve velikih bronhov ali bronhiolov. Spadajo med redkejše bolezni s prevalenco 67/100.000 prebivalcev.
Mitja Košnik, Peter Kopač, Irena Šarc, Sabina Škrgat, Marija Iča Dolenšek, Natalija Edelbaher, Boris Greif, Frosina Ilovski, Biljana Knežević, Tatjana Kosten, Tadeja Kotar, Mateja Marc Malovrh, Tadeja Matos, Tina Morgan, Ilonka Osrajnik, Davorina Petek, Igor Požek, Tjaša Romih, Barbara Salobir, Katja Seme, Petra Svetina, Julij Šelb, Nina Špes, Tjaša Šubic   +23 more
doaj   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

British Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Creutzfelt-Jakobova bolezen in njen pomen v transfuzijski medicini

Zdravniški Vestnik
Creutzfeldt-Jakobova bolezen (CJB) je neozdravljiva nevrodegenerativna bolezen, ki spada med prenosljive spongiformne encefalopatije. Posebno pozornost v transfuzijski medicini ima variantna oblika CJB (vCJB), ki se lahko prenaša s krvnimi pripravki ...
Brina Šebez, Klara Železnik, Valentina Filipović Samec, Nuška Čakš Jager, Polonca Mali   +4 more
doaj   +1 more source